Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Rubin

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamideA B Shahripour, M S Plummer, E A Lunney, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamideA B Shahripour, M S Plummer, E A Lunney, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 8